| Patents for A61P 33 - Antiparasitic agents (21,787) |
|---|
| 09/13/2001 | US20010021517 An isolated nucleic acid molecule that hybridizes under stringent hybridization conditions with macrophase migration inhibiatory factor (MIF) gene selected from dirofilaria immitis MIF gene and Onchocerca volvulus MIF gene |
| 09/13/2001 | CA2402315A1 Therapeutic uses of ppar mediators |
| 09/13/2001 | CA2402211A1 Phosphatidyl serine receptors and uses thereof |
| 09/13/2001 | CA2401524A1 New ccr5 modulators: benzimidazoles or benzotriazoles |
| 09/13/2001 | CA2401454A1 G-protein coupled receptors |
| 09/13/2001 | CA2401323A1 Treatment of diseases associated with cytokine production with inhibitors of the tec family of protein tyrosine kinases |
| 09/13/2001 | CA2399913A1 Adam polynucleotides, polypeptides, and antibodies |
| 09/12/2001 | EP1132392A1 Ketolide antibiotics |
| 09/12/2001 | EP1131331A1 13-membered azalides and their use as antibiotic agents |
| 09/12/2001 | EP1131314A1 Compounds having cytokine inhibitory activity |
| 09/12/2001 | EP1131292A2 Acyclic and cyclic guanidine- and acetamidine derivatives, their preparation and their use as pesticides, esp. as parasiticides |
| 09/12/2001 | EP1131290A1 Piperidine ccr-3 receptor antagonists |
| 09/12/2001 | EP1131075A2 Use of phosphonoformic acid derivatives for treating infections |
| 09/12/2001 | EP1130966A1 Antiparasitic formulations |
| 09/12/2001 | CN1312105A External-use liposome prepn for treating mite-borne dermatosis |
| 09/07/2001 | WO2001064943A1 Method of screening substance specifically inhibiting non-mevalonate pathway |
| 09/07/2001 | WO2001064879A2 G-proteins coupled receptor related polypeptides |
| 09/07/2001 | WO2001064691A1 Il-8 receptor antagonists |
| 09/07/2001 | WO2001064682A1 Novel compound having antimalarial activity |
| 09/07/2001 | WO2001064679A1 1,5-disubstituted-3,4-dihydro-1h-pyrimido[4,5-d]pyrimidin-2-one compounds and their use in treating csbp/p38 kinase mediated diseases |
| 09/07/2001 | WO2001064673A1 Flavone derivatives, preparation method and use as medicines |
| 09/07/2001 | WO2001064669A1 Pyrazole ether derivatives as anti-inflammatory/analgesic agents |
| 09/07/2001 | WO2001064243A2 Use of toxoplasma gondii mic3 protein as immunogenic agent |
| 09/07/2001 | WO2001064225A1 Carbohydrate formulation (prebiotic adjuvant) for enhancement of immune response |
| 09/07/2001 | WO2001064222A1 Veterinary compositions for the treatment of parasitic diseases |
| 09/07/2001 | WO2001064208A1 Il-8 receptor antagonists |
| 09/07/2001 | WO2001064165A2 Il-8 receptor antagonists |
| 09/07/2001 | WO2001010383A3 Caspase inhibitors and uses thereof |
| 09/07/2001 | WO2001005823A3 Tryptase inhibitor |
| 09/07/2001 | CA2401697A1 Pyrazole ether derivatives as anti-inflammatory/analgesic agents |
| 09/07/2001 | CA2401659A1 Il-8 receptor antagonists |
| 09/07/2001 | CA2401453A1 G-proteins coupled receptor related polypeptides |
| 09/07/2001 | CA2339676A1 Use of heteroaryl substituted n-(indole-2-carbonyl-) amides for treatment of infection |
| 09/06/2001 | DE10008522A1 Verwendung von 2-PHenylendiaminderivaten zur Behandlung von Infektionen Use of 2-phenylenediamine for the treatment of infections |
| 09/06/2001 | CA2339051A1 Ketolide antibiotics |
| 09/05/2001 | EP1130019A1 2,4-bis((4-Amidino)phenyl)furans as anti-pneumocystis carinii agents |
| 09/05/2001 | EP1129713A1 Veterinary compositions for the treatment of parasitic diseases |
| 09/05/2001 | EP1129217A2 Compositions and methods of disease diagnosis and therapy |
| 09/05/2001 | EP1129189A2 Human cell surface receptor proteins |
| 09/05/2001 | EP1128813A1 An inhalation system |
| 09/05/2001 | CN1311009A Method for treating pesticide residue in ginseng and other Chinese herbal medicine extract |
| 09/05/2001 | CN1070481C Use of dioxomorpholines to combact endopharasites, movel dioxomopholines and process for their prodn. |
| 09/04/2001 | US6284268 Cyclosporin, synergistic |
| 08/30/2001 | WO2001062709A2 Use of 2-phenylene diamine derivatives for the treatment of infections |
| 08/30/2001 | WO2001062312A1 Foam-forming wound dressing |
| 08/30/2001 | WO2001062275A1 Adjuvant treatment by in vivo activation of dendritic cells |
| 08/30/2001 | WO2001062268A1 Endoparasiticidal agents |
| 08/30/2001 | US20010018443 Antiproliferative substituted 5-thiapyrimidinone and 5-selenopyrimidinone compounds |
| 08/30/2001 | CA2401030A1 Use of 2-phenylene diamine derivatives for the treatment of infections |
| 08/30/2001 | CA2400610A1 Endoparasiticidal compositions comprising a cyclic depsipeptide |
| 08/30/2001 | CA2399211A1 Foam-forming wound dressing |
| 08/29/2001 | EP1127883A2 Oxamides as IMPDH inhibitors |
| 08/29/2001 | EP1126876A2 Adjuvant systems and vaccines |
| 08/29/2001 | EP1126860A2 Immunomodulatory factors for immunosuppressant and antiallergic treatment |
| 08/29/2001 | EP1126852A1 Pyridin-4-yl or pyrimidin-4-yl substituted pyrazines |
| 08/29/2001 | EP0963198A4 ANTI-PARASITIC ACTION OF N,N-DIETHYL-m-TOLUAMIDE (DEET) AND FORMULATIONS THAT PROLONG ITS ACTIVITY IN THE SKIN |
| 08/29/2001 | CN1310179A Oxamide being as IMPDH inhibitor |
| 08/24/2001 | CA2337588A1 Oxamides as impdh inhibitors |
| 08/23/2001 | WO2001061000A1 5ht3 receptors of nematodes, polynucleotide molecules encoding same, and antagonists thereof |
| 08/23/2001 | WO2001060829A1 Phosphororganic compounds and the use thereof |
| 08/23/2001 | WO2001060801A2 9-alkylamino-1-nitroacridine derivatives |
| 08/23/2001 | WO2001060409A1 Improved paste formulations |
| 08/23/2001 | WO2001060381A1 Nucleoside analogs with carboxamidine-modified bicyclic base |
| 08/23/2001 | WO2001060379A1 Nucleoside analogs with carboxamidine modified monocyclic base |
| 08/23/2001 | WO2001060378A2 Antiadhesive carbohydrates |
| 08/23/2001 | WO2001009341A3 Method of determining the activity of 1-deoxy-d-xylulose-5-phosphate reductoisomerase and 1-deoxy-d-xylulose-5-phosphate synthase |
| 08/23/2001 | US20010016574 9a,11b-dehydro derivatives of 9-oxime-3-keto-6-O- methylerythromycin |
| 08/23/2001 | US20010016207 Compounds such as N-(1-(cyanomethylcarbamoyl)cyclohexyl)-4-(piperazin-1-yl)-benzamide |
| 08/23/2001 | DE10008128A1 Endoparasiticide composition effective on topical administration, comprises solution of depsipeptide in solvent such as 1,2-isopropylidene-glycerol |
| 08/23/2001 | DE10006989A1 Pharmaceutical or dietetic preparation for preventing cellular adhesion of pathogens, e.g. in treatment of infections, comprising carbohydrate having double bond-containing terminal uronic acid unit |
| 08/23/2001 | CA2765218A1 Antiadhesive carbohydrates comprising a terminal uronic acid unit containing a carbon-carbon double bond |
| 08/23/2001 | CA2399947A1 Phosphororganic compounds and the use thereof |
| 08/23/2001 | CA2398628A1 5ht3 receptors of nematodes, polynucleotide molecules encoding same, andantagonists thereof |
| 08/23/2001 | CA2395854A1 Nucleoside analogs with carboxamidine-modified bicyclic base |
| 08/22/2001 | EP1125936A2 Aryl substituted azabenzimidazoles and their use in the treatment of HIV and AIDS related diseases |
| 08/22/2001 | EP1124850A1 12 human secreted proteins |
| 08/22/2001 | EP1124837A2 Novel macrolide antibiotics |
| 08/22/2001 | EP1124576A2 Method for preparing solid phase conjugate vaccines |
| 08/22/2001 | EP0824536B1 Antimalarial organometallic iron complexes |
| 08/22/2001 | CN1309659A Phosphorous organic compounds and their use |
| 08/21/2001 | US6277977 cDNA clone HAPOI67 that encodes a human 7-transmembrane receptor |
| 08/16/2001 | WO2001059071A2 Methods of preparing and using a viral vector library |
| 08/16/2001 | WO2001058956A2 Antibodies that bind human interleukin-18 and methods of making and using |
| 08/16/2001 | WO2001058937A2 Interferon-alpha induced genes |
| 08/16/2001 | WO2001058896A1 Benzoxazole derivatives as tnf and pde iv inhibitors |
| 08/16/2001 | WO2001058888A1 A sesquiterpenoic compound and pharmaceutical formulations comprising the same |
| 08/16/2001 | WO2001058886A1 Dipeptide nitrile cathepsin k inhibitors |
| 08/16/2001 | WO2001058480A2 Tubulin based vaccine against trypanosomiasis |
| 08/16/2001 | WO2001058464A1 Water dispersed ivermectin dosage form used for curing ecto- and endoparasitic diseases |
| 08/16/2001 | WO2001007628A3 Human synthetases |
| 08/16/2001 | WO2001004123A3 Peroxide-based antimalarial compounds |
| 08/16/2001 | WO2001002569A3 Human immune response molecules |
| 08/16/2001 | EP1123396A2 Minimal promoters and uses thereof |
| 08/16/2001 | EP1123309A2 Cyclic tetrapeptides and their use as histone deacetylase inhibitor |
| 08/16/2001 | CA2800450A1 Antibodies that bind human interleukin-18 and methods of making and using |
| 08/16/2001 | CA2399148A1 Antibodies that bind human interleukin-18 and methods of making and using |
| 08/16/2001 | CA2397254A1 Interferon-alpha induced genes |
| 08/09/2001 | WO2001057267A1 Methods and materials relating to cub domain polypeptides and polynucleotides |
| 08/09/2001 | WO2001057261A1 Methods and materials relating to leucine-rich repeat protein-like (lrr protein-like) polypeptides and polynucleotides |
| 08/09/2001 | WO2001057175A2 Methods and materials relating to neurotrimin-like polypeptides and polynucleotides |